[ClickPress, Mon Mar 11 2019] The growing inclination of consumer towards high protein consumption and healthy lifestyle is driving the demand in the marine
collagens market.
Jellagen, a marine biotechnology company based in the Welsh capital, has just expanded to begin the extraction of high-purity collagen from jellyfish at a new custom-built base at Wentloog Industrial Estate.
The small team of 12 is the first commercial manufacturer of jellyfish collagen for research purposes and for the medical, biotech and pharmaceutical markets in Europe.
CLEVELAND, Ohio, June 4, 2018 -- Viscus Biologics, LLC, a maker of allograft and xenograft extracellular matrix materials for biomedical applications, has launched a high concentration solubilized collagen for use in drug screening and testing.
Collagen is a fibrous protein found in connective tissue.
GLOBAL SALES of collagen products are expected to reach $9.3 billion by 2023 and the market for nutricosmetics will be worth $7.4 billion by 2020 driven, in part, by an aging population and a growing acceptance of functional foods, according to a report by Transparency Market Research Company.
The word collagen comes from two Greek terms: kola meaning "glue" and gen meaning "producing." Collagen has glue-like properties; think of it as the building block that keeps skin firm and resilient.
At present,
collagen is widely added to the productions with high recognition and brilliant effective in cosmetic and functional food.
Almost 30% of the body's protein comprises
collagen. It is one of the crucial building blocks of the human body.
It is used in the research, medical, biotech and pharmaceutical world to grow new human tissue and organs and to make specialist
collagen dressings to attract new skin cells to wound sites.
Collagen is the most abundant protein of the human body that forms the basis of the extracellular matrix (ECM) in most tissues and is a key component of healing wounds [1], [2].
